BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance

  October 30, 2024

   · 

  18 min read
• Press Releases

  HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer

  October 30, 2024

   · 

  7 min read
• Press Releases

  MacroGenics Announces Leadership Transition

  October 30, 2024

   · 

  6 min read
• Press Releases

  CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update

  October 30, 2024

   · 

  8 min read
• Press Releases

  Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

  October 30, 2024

   · 

  7 min read
• Press Releases

  AbbVie Reports Third-Quarter 2024 Financial Results

  October 30, 2024

   · 

  28 min read
• Press Releases

  Madrigal Pharmaceuticals to Present Multiple Rezdiffra™ (resmetirom) Abstracts in NASH/MASH at the AASLD Liver Meeting®

  October 30, 2024

   · 

  10 min read
• Press Releases

  Numab Therapeutics Announces Initiation of Phase 1 Clinical Study of NM32 Program in Patients with Solid Tumors

  October 30, 2024

   · 

  3 min read
• Press Releases

  COUR Pharmaceuticals Doses First Patient in Phase 1b/2a Clinical Trial Evaluating CNP-106 in Generalized Myasthenia Gravis

  October 30, 2024

   · 

  2 min read
• Press Releases

  Inspire Medical Systems, Inc. to Present at UBS Global Healthcare Conference

  October 30, 2024

   · 

  1 min read